View Item 

Show simple item record

Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists

dc.contributor.authorBitar, Carole
dc.contributor.authorMenge, Tyler D
dc.contributor.authorChan, May P
dc.date.accessioned2022-01-06T15:48:51Z
dc.date.available2023-02-06 10:48:49en
dc.date.available2022-01-06T15:48:51Z
dc.date.issued2022-01
dc.identifier.citationBitar, Carole; Menge, Tyler D; Chan, May P (2022). "Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists." Histopathology (1): 233-250.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/171156
dc.publisherWiley Periodicals, Inc.
dc.subject.othervasculitis
dc.subject.otherlupus erythematosus
dc.subject.otherantiphospholipid syndrome
dc.subject.otherconnective tissue disease
dc.subject.otherplasmacytoid dendritic cells
dc.titleCutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171156/1/his14440_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171156/2/his14440.pdf
dc.identifier.doi10.1111/his.14440
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceVitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol. 1992; 10; 527 – 539.
dc.identifier.citedreferenceLee LA. Maternal autoantibodies and pregnancy – II. The neonatal lupus syndrome. Baillières. Clin. Rheumatol. 1990; 4; 69 – 84.
dc.identifier.citedreferenceFujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K. Bullous systemic lupus erythematosus as an initial manifestation of SLE. J. Dermatol. 2005; 32; 1021 – 1027.
dc.identifier.citedreferenceGammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J. Invest. Dermatol. 1993; 100; 28s – 34s.
dc.identifier.citedreferenceCamisa C, Sharma HM. Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. J. Am. Acad. Dermatol. 1983; 9; 924 – 933.
dc.identifier.citedreferenceYell JA, Allen J, Wojnarowska F, Kirtschig G, Burge SM. Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br. J. Dermatol. 1995; 132; 921 – 928.
dc.identifier.citedreferenceCamisa C. Vesiculobullous systemic lupus erythematosus. A report of four cases. J. Am. Acad. Dermatol. 1988; 18; 93 – 100.
dc.identifier.citedreferenceAnyanwu CO, Ang CC, Werth VP. Oral mucosal involvement in bullous lupus. Arthritis Rheum. 2013; 65; 2622.
dc.identifier.citedreferenceVassileva S. Bullous systemic lupus erythematosus. Clin. Dermatol 2004; 22; 129 – 138.
dc.identifier.citedreferenceNg YY, Chang IT, Chen TW, Liou HN, Yang AH, Yang WC. Concomitant lupus nephritis and bullous eruption in systemic lupus erythematosus. Nephrol. Dial. Transplant. 1999; 14; 1739 – 1743.
dc.identifier.citedreferenceBurrows NP, Bhogal BS, Black MM et al. Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. Br. J. Dermatol. 1993; 128; 332 – 338.
dc.identifier.citedreferenceGammon WR, Woodley DT, Dole KC, Briggaman RA. Evidence that anti‐basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J. Invest. Dermatol. 1985; 84; 472 – 476.
dc.identifier.citedreferenceVodegel RM, Jonkman MF, Pas HH, de Jong MC. U‐serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br. J. Dermatol. 2004; 151; 112 – 118.
dc.identifier.citedreferenceKieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine 2009; 88; 23 – 31.
dc.identifier.citedreferenceMehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J. Am. Acad. Dermatol. 1992; 26; 441 – 448.
dc.identifier.citedreferenceGusdorf L, Bessis D, Lipsker D. Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients. Medicine. 2014; 93; e351.
dc.identifier.citedreferenceBroekaert SMC, Böer‐Auer A, Kerl K et al. Neutrophilic epitheliotropism is a histopathological clue to neutrophilic urticarial dermatosis. Am. J. Dermatopathol. 2016; 38; 39 – 49.
dc.identifier.citedreferenceBrinster NK, Nunley J, Pariser R, Horvath B. Nonbullous neutrophilic lupus erythematosus: a newly recognized variant of cutaneous lupus erythematosus. J. Am. Acad. Dermatol. 2012; 66; 92 – 97.
dc.identifier.citedreferenceGleason BC, Zembowicz A, Granter SR. Non‐bullous neutrophilic dermatosis: an uncommon dermatologic manifestation in patients with lupus erythematosus. J. Cutan. Pathol. 2006; 33; 721 – 725.
dc.identifier.citedreferenceSchissler C, Velter C, Lipsker D. Amicrobial pustulosis of the folds: Where have we gone 25 years after its original description? Ann. Dermatol. Venereol. 2017; 144; 169 – 175.
dc.identifier.citedreferenceBoms S, Gambichler T. Review of literature on amicrobial pustulosis of the folds associated with autoimmune disorders. Am. J. Clin. Dermatol. 2006; 7; 369 – 374.
dc.identifier.citedreferenceWang MZ, Camilleri MJ, Guo R, Wieland CN. Amicrobial pustulosis of the folds: report of 4 cases. J. Cutan. Pathol. 2017; 44; 367 – 372.
dc.identifier.citedreferenceMéndez‐Flores S, Charli‐Joseph Y, Saeb‐Lima M, Orozco‐Topete R, Fernández SM. Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis. Dermatology 2013; 226; 1 – 4.
dc.identifier.citedreferencePons‐Estel GJ, Ugarte‐Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Exp. Rev. Clin. Immunol 2017; 13; 799 – 814.
dc.identifier.citedreferenceTebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6; 96 – 104.
dc.identifier.citedreferenceWysenbeek AJ, Guedj D, Amit M, Weinberger A. Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non‐cutaneous disease manifestations. Ann. Rheum. Dis. 1992; 51; 717 – 719.
dc.identifier.citedreferenceDurosaro O, Davis MD, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965–2005: a population‐based study. Arch. Dermatol. 2009; 145; 249 – 253.
dc.identifier.citedreferenceGrönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population‐based cohort of 1088 patients in Sweden. Br. J. Dermatol. 2011; 164; 1335 – 1341.
dc.identifier.citedreferenceGilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J. Am. Acad. Dermatol. 1981; 4; 471 – 475.
dc.identifier.citedreferenceRibero S, Sciascia S, Borradori L, Lipsker D. The cutaneous spectrum of lupus erythematosus. Clin. Rev. Allergy Immunol. 2017; 53; 291 – 305.
dc.identifier.citedreferenceWalling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am. J. Clin. Dermatol. 2009; 10; 365 – 381.
dc.identifier.citedreferenceAslani FS, Sepaskhah M, Bagheri Z, Akbarzadeh‐Jahromi M. Value of CD123 immunohistochemistry and elastic staining in differentiating discoid lupus erythematosus from lichen planopilaris. Int. J. Trichol. 2020; 12; 62 – 67.
dc.identifier.citedreferenceZiemer M, Kardaun SH, Liss Y, Mockenhaupt M. Stevens‐Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. Br. J. Dermatol. 2012; 166; 575 – 600.
dc.identifier.citedreferenceTankunakorn J, Sawatwarakul S, Vachiramon V, Chanprapaph K. Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like lupus erythematosus. J. Clin. Rheumatol. 2019; 25; 224 – 231.
dc.identifier.citedreferenceFilotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico‐pathologic correlation. G. Ital. Dermatol. Venereol 2018; 153; 216 – 229.
dc.identifier.citedreferenceBaltaci M, Fritsch P. Histologic features of cutaneous lupus erythematosus. Autoimmun. Rev. 2009; 8; 467 – 473.
dc.identifier.citedreferenceSafi R, Al‐Hage J, Abbas O, Kibbi AG, Nassar D. Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus. Exp. Dermatol. 2019; 28; 1348 – 1352.
dc.identifier.citedreferenceTing W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis‐like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan‐epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus 2004; 13; 941 – 950.
dc.identifier.citedreferenceRomero LS, Bari O, Forbess Smith CJ, Schneider JA, Cohen PR. Toxic epidermal necrolysis‐like acute cutaneous lupus erythematosus: report of a case and review of the literature. Dermatol. Online J. 2018; 24; 13030/qt5r79d67k.
dc.identifier.citedreferenceReich A, Marcinow K, Bialynicki‐Birula R. The lupus band test in systemic lupus erythematosus patients. Ther. Clin. Risk Manag. 2011; 7; 27 – 732.
dc.identifier.citedreferenceCardinali C, Caproni M, Fabbri P. The utility of the lupus band test on sun‐protected non‐lesional skin for the diagnosis of systemic lupus erythematosus. Clin. Exp. Rheumatol. 1999; 17; 427 – 432.
dc.identifier.citedreferenceBurrows NP, Bhogal BS, Russell Jones R, Black MM. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J. Cutan. Pathol. 1993; 20; 159 – 162.
dc.identifier.citedreferenceLipsker D. The need to revisit the nosology of cutaneous lupus erythematosus: the current terminology and morphologic classification of cutaneous LE: difficult, incomplete and not always applicable. Lupus 2010; 19; 1047 – 1049.
dc.identifier.citedreferenceWollina U, Hein G. Lupus erythematosus: uncommon presentations. Clin. Dermatol. 2005; 23; 470 – 479.
dc.identifier.citedreferenceSontheimer RD. Subacute cutaneous lupus erythematosus: 25‐year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun. Rev. 2005; 4; 253 – 263.
dc.identifier.citedreferenceTiao J, Feng R, Carr K, Okawa J, Werth VP. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). J. Am. Acad. Dermatol. 2016; 74; 862 – 869.
dc.identifier.citedreferenceGuicciardi F, Atzori L, Marzano AV et al. Are there distinct clinical and pathological features distinguishing idiopathic from drug‐induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study. J. Am. Acad. Dermatol. 2019; 81; 403 – 411.
dc.identifier.citedreferenceVázquez‐Doval J, Ruiz de Erenchun F, Sánchez‐Ibarrola A, Contreras F, Soto de Delás J, Quintanilla E. Subacute cutaneous lupus erythematosus – clinical, histopathological and immunophenotypical study of five cases. J. Invest. Allergol. Clin. Immunol. 1992; 2; 27 – 32.
dc.identifier.citedreferenceParodi A, Caproni M, Cardinali C et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology. Dermatology 2000; 200; 6 – 10.
dc.identifier.citedreferenceVera‐Recabarren MA, García‐Carrasco M, Ramos‐Casals M, Herrero C. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Br. J. Dermatol. 2010; 162; 91 – 101.
dc.identifier.citedreferenceLee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch. Dermatol. 1994; 130; 1262 – 1268.
dc.identifier.citedreferenceHerrero C, Bielsa I, Font J et al. Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J. Am. Acad. Dermatol. 1988; 19; 1057 – 1062.
dc.identifier.citedreferenceAntiga E, Caproni M, Bonciani D, Bonciolini V, Fabbri P. The last word on the so‐called ‘Rowell’s syndrome’? Lupus 2012; 21; 577 – 585.
dc.identifier.citedreferenceGeorge R, Mathai R, Kurian S. Cutaneous lupus erythematosus in India: immunofluorescence profile. Int. J. Dermatol. 1992; 31; 265 – 269.
dc.identifier.citedreferenceNieboer C, Tak‐Diamand Z, Van Leeuwen‐Wallau HE. Dust‐like particles: a specific direct immunofluorescence pattern in sub‐acute cutaneous lupus erythematosus. Br. J. Dermatol. 1988; 118; 725 – 729.
dc.identifier.citedreferenceLipsker D, Di Cesare MP, Cribier B, Grosshans E, Heid E. The significance of the ’dust‐like particles’ pattern of immunofluorescence. A study of 66 cases. Br. J. Dermatol. 1998; 138; 1039 – 1042.
dc.identifier.citedreferenceOh EH, Kim EJ, Ro YS, Ko JY. Ten‐year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea. J. Dermatol. 2018; 45; 436 – 443.
dc.identifier.citedreferenceRakhshan A, Toossi P, Amani M, Dadkhahfar S, Hamidi AB. Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining. An. Bras. Dermatol. 2020; 95; 307 – 313.
dc.identifier.citedreferenceWalsh NM, Lai J, Hanly JG et al. Plasmacytoid dendritic cells in hypertrophic discoid lupus erythematosus: an objective evaluation of their diagnostic value. J. Cutan. Pathol. 2015; 42; 32 – 38.
dc.identifier.citedreferenceDaldon PE, Macedo de Souza E, Cintra ML. Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J. Cutan. Pathol. 2003; 30; 443 – 448.
dc.identifier.citedreferenceShah K, Kazlouskaya V, Lal K, Molina D, Elston DM. Perforating elastic fibers (‘elastic fiber trapping’) in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia. J. Cutan. Pathol. 2014; 41; 108 – 112.
dc.identifier.citedreferenceGeorge R, Kurian S, Jacob M, Thomas K. Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int. J. Dermatol. 1995; 34; 170 – 173.
dc.identifier.citedreferenceWeigand DA. Lupus band test: anatomic regional variations in discoid lupus erythematosus. J. Am. Acad. Dermatol. 1986; 14; 426 – 428.
dc.identifier.citedreferenceMillard LG, Rowell NR. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients. Br. J. Dermatol. 1978; 98; 497 – 506.
dc.identifier.citedreferenceHedrich CM, Fiebig B, Hauck FH et al. Chilblain lupus erythematosus – a review of literature. Clin. Rheumatol. 2008; 27; 949 – 954.
dc.identifier.citedreferenceFranceschini F, Calzavara‐Pinton P, Valsecchi L et al. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Adv. Exp. Med. Biol 1999; 455; 167 – 171.
dc.identifier.citedreferenceSu WP, Perniciaro C, Rogers RS III, White JW Jr. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 1994; 54; 395 – 399.
dc.identifier.citedreferenceDoutre MS, Beylot C, Beylot J, Pompougnac E, Royer P. Chilblain lupus erythematosus: report of 15 cases. Dermatology 1992; 184; 26 – 28.
dc.identifier.citedreferenceCrowson AN, Magro CM. Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases. Hum. Pathol. 1997; 28; 478 – 484.
dc.identifier.citedreferenceWang ML, Chan MP. Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: histopathologic features and immunohistochemistry for CD123 and CD30. Am. J. Dermatopathol. 2018; 40; 265 – 271.
dc.identifier.citedreferenceCribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J. Am. Acad. Dermatol. 2001; 45; 924 – 929.
dc.identifier.citedreferenceBoada A, Bielsa I, Fernández‐Figueras MT, Ferrándiz C. Perniosis: clinical and histopathological analysis. Am. J. Dermatopathol. 2010; 32; 19 – 23.
dc.identifier.citedreferenceRequena L, Sánchez YE. Panniculitis. Part II. Mostly lobular panniculitis.. J. Am. Acad. Dermatol. 2001; 45; 325 – 364; quiz 62–64.
dc.identifier.citedreferenceFraga J, García‐Díez A. Lupus erythematosus panniculitis. Dermatol. Clin. 2008; 26 ( 4 ); 453 – 463, vi.
dc.identifier.citedreferenceArnold HL Jr. Lupus erythematosus profundus (Kaposi–Irgang) historical review and report of a case. Arch. Derm. Syphilol. 1948; 57; 196 – 203.
dc.identifier.citedreferenceMartens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J. Rheumatol. 1999; 26; 68 – 72.
dc.identifier.citedreferenceRangel LK, Villa‐Ruiz C, Lo K et al. Clinical characteristics of lupus erythematosus panniculitis/profundus: a retrospective review of 61 patients. JAMA Dermatol. 2020; 156; 1264 – 1266.
dc.identifier.citedreferenceVerdier M, Anuardo P, Gormezano NWS et al. Panniculitis in childhood‐onset systemic lupus erythematosus: a multicentric cohort study. Adv. Rheumatol. 2019; 59; 3.
dc.identifier.citedreferencePeters MS, Su WP. Lupus erythematosus panniculitis. Med. Clin. North Am. 1989; 73; 1113 – 1126.
dc.identifier.citedreferenceSánchez NP, Peters MS, Winkelmann RK. The histopathology of lupus erythematosus panniculitis. J. Am. Acad. Dermatol. 1981; 5; 673 – 680.
dc.identifier.citedreferenceArai S, Katsuoka K. Clinical entity of lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun. Rev. 2009; 8; 449 – 452.
dc.identifier.citedreferenceFountain RB. Lupus erythematosus profundus. Br. J. Dermatol. 1968; 80; 571 – 579.
dc.identifier.citedreferenceMassone C, Kodama K, Salmhofer W et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J. Cutan. Pathol. 2005; 32; 396 – 404.
dc.identifier.citedreferenceAlegre VA, Winkelmann RK, Aliaga A. Lipomembranous changes in chronic panniculitis. J. Am. Acad. Dermatol. 1988; 19; 39 – 46.
dc.identifier.citedreferencePark HS, Choi JW, Kim BK, Cho KH. Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies. Am. J. Dermatopathol. 2010; 32; 24 – 30.
dc.identifier.citedreferenceMassone C, Chott A, Metze D et al. Subcutaneous, blastic natural killer (NK), NK/T‐cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am. J. Surg. Pathol. 2004; 28; 719 – 735.
dc.identifier.citedreferenceSitthinamsuwan P, Pattanaprichakul P, Treetipsatit J et al. Subcutaneous panniculitis‐like T‐cell lymphoma versus lupus erythematosus panniculitis: distinction by means of the periadipocytic cell proliferation index. Am. J. Dermatopathol. 2018; 40; 567 – 574.
dc.identifier.citedreferenceLeBlanc RE, Tavallaee M, Kim YH, Kim J. Useful parameters for distinguishing subcutaneous panniculitis‐like T‐cell lymphoma from lupus erythematosus panniculitis. Am. J. Surg. Pathol. 2016; 40; 745 – 754.
dc.identifier.citedreferenceChen SJT, Tse JY, Harms PW, Hristov AC, Chan MP. Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma. Histopathology. 2019; 74; 908 – 916.
dc.identifier.citedreferenceTuffanelli DL. Lupus erythematosus panniculitis (profundus). Arch. Dermatol. 1971; 103; 231 – 242.
dc.identifier.citedreferenceMarks R, Levene GM. Discoid lupus erythematosus and lupus erythematosus profundus in a child. Clin. Exp. Dermatol. 1976; 1; 187 – 190.
dc.identifier.citedreferenceAlexiades‐Armenakas MR, Baldassano M, Bince B et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum. 2003; 49; 494 – 500.
dc.identifier.citedreferenceObermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 2010; 19; 1050 – 1070.
dc.identifier.citedreferenceJatwani K, Chugh K, Osholowu OS, Jatwani S. Tumid lupus erythematosus and systemic lupus erythematosus: a report on their rare coexistence. Cureus 2020; 12; e7545.
dc.identifier.citedreferencePatsinakidis N, Kautz O, Gibbs BF, Raap U. Lupus erythematosus tumidus: clinical perspectives. Clin. Cosmet. Invest. Dermatol. 2019; 12; 707 – 719.
dc.identifier.citedreferenceCozzani E, Christana K, Rongioletti F, Rebora A, Parodi A. Lupus erythematosus tumidus: clinical, histopathological and serological aspects and therapy response of 21 patients. Eur. J. Dermatol. 2010; 20; 797 – 801.
dc.identifier.citedreferenceRodriguez‐Caruncho C, Bielsa I, Fernández‐Figueras MT, Roca J, Carrascosa JM, Ferrándiz C. Lupus erythematosus tumidus: a clinical and histological study of 25 cases. Lupus 2015; 24; 751 – 755.
dc.identifier.citedreferenceVerdelli A, Coi A, Marzano AV et al. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus. J. Eur. Acad. Dermatol. Venereol. 2019; 33; 742 – 752.
dc.identifier.citedreferenceKuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J. Am. Acad. Dermatol. 2003; 48; 901 – 908.
dc.identifier.citedreferenceVincent JG, Chan MP. Specificity of dermal mucin in the diagnosis of lupus erythematosus: comparison with other dermatitides and normal skin. J. Cutan. Pathol. 2015; 42; 722 – 729.
dc.identifier.citedreferenceWackernagel A, Massone C, Hoefler G, Steinbauer E, Kerl H, Wolf P. Plasmacytoid dendritic cells are absent in skin lesions of polymorphic light eruption. Photodermatol. Photoimmunol. Photomed. 2007; 23; 24 – 28.
dc.identifier.citedreferenceTomasini D, Mentzel T, Hantschke M et al. Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner’s lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J. Cutan. Pathol. 2010; 37; 1132 – 1139.
dc.identifier.citedreferenceMolina‐Ruiz AM, Sanmartín O, Santonja C, Kutzner H, Requena L. Spring and summer eruption of the elbows: a peculiar localized variant of polymorphous light eruption. J. Am. Acad. Dermatol. 2013; 68; 306 – 312.
dc.identifier.citedreferenceWeyers W, Bonczkowitz M, Weyers I. LE or not LE – that is the question: an unsuccessful attempt to separate lymphocytic infiltration from the spectrum of discoid lupus erythematosus. Am. J. Dermatopathol. 1998; 20; 225 – 232.
dc.identifier.citedreferenceWeber F, Schmuth M, Fritsch P, Sepp N. Lymphocytic infiltration of the skin is a photosensitive variant of lupus erythematosus: evidence by phototesting. Br. J. Dermatol. 2001; 144; 292 – 296.
dc.identifier.citedreferenceRuiz H, Sánchez JL. Tumid lupus erythematosus. Am. J. Dermatopathol. 1999; 21; 356 – 360.
dc.identifier.citedreferenceLee LA. Neonatal lupus erythematosus. J. Invest. Dermatol. 1993; 100; 9s – 13s.
dc.identifier.citedreferenceLee LA. Neonatal lupus: clinical features and management. Paediatr. Drugs. 2004; 6; 71 – 78.
dc.identifier.citedreferenceWeston WL, Morelli JG, Lee LA. The clinical spectrum of anti‐Ro‐positive cutaneous neonatal lupus erythematosus. J. Am. Acad. Dermatol. 1999; 40; 675 – 681.
dc.identifier.citedreferencePeñate Y, Guillermo N, Rodríguez J et al. Histopathologic characteristics of neonatal cutaneous lupus erythematosus: description of five cases and literature review. J. Cutan. Pathol. 2009; 36; 660 – 667.
dc.identifier.citedreferenceBuyon JP, Hiebert R, Copel J et al. Autoimmune‐associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 1998; 31; 1658 – 1666.
dc.identifier.citedreferenceProvost TT, Watson R, Gammon WR, Radowsky M, Harley JB, Reichlin M. The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N. Engl. J. Med. 1987; 316; 1135 – 1138.
dc.identifier.citedreferenceZuppa AA, Riccardi R, Frezza S et al. Neonatal lupus: follow‐up in infants with anti‐SSA/Ro antibodies and review of the literature. Autoimmun. Rev. 2017; 16; 427 – 432.
dc.identifier.citedreferenceBangert JL, Freeman RG, Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch. Dermatol. 1984; 120; 332 – 337.
dc.identifier.citedreferenceSatter EK, High WA. Non‐bullous neutrophilic dermatosis within neonatal lupus erythematosus. J. Cutan. Pathol. 2007; 34; 958 – 960.
dc.identifier.citedreferenceLee SH, Roh MR. Targetoid lesions and neutrophilic dermatosis: an initial clinical and histological presentation of neonatal lupus erythematosus. Int. J. Dermatol. 2014; 53; 764 – 766.
dc.identifier.citedreferenceSitthinamsuwan P, Nitiyarom R, Chairatchaneeboon M, Wisuthsarewong W. Histiocytoid neutrophilic dermatitis, an unusual histopathology in neonatal lupus erythematosus. J. Cutan. Pathol. 2015; 42; 996 – 999.
dc.identifier.citedreferenceD’Cruz D. Vasculitis in systemic lupus erythematosus. Lupus 1998; 7; 270 – 274.
dc.identifier.citedreferenceYang X. Clinical features, autoantibodies, and outcome of neonatal lupus erythematosus. Fetal Pediatr. Pathol. 2020; 39; 1 – 7.
dc.identifier.citedreferenceDrenkard C, Villa AR, Reyes E, Abello M, Alarcón‐Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6; 235 – 242.
dc.identifier.citedreferenceBerti S, Moretti S, Lucin C, Amato L, Massi D, Fabbri P. Urticarial vasculitis and subacute cutaneous lupus erythematosus. Lupus 2005; 14; 489 – 492.
dc.identifier.citedreferenceCrowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J. Cutan. Pathol. 2001; 28; 1 – 23.
dc.identifier.citedreferenceLath K, Chatterjee D, Saikia UN et al. Role of direct immunofluorescence in cutaneous small‐vessel vasculitis: experience from a tertiary center. Am. J. Dermatopathol. 2018; 40; 661 – 666.
dc.identifier.citedreferenceAsherson RA, Khamashta MA, Ordi‐Ros J et al. The ‘primary’ antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68; 366 – 374.
dc.identifier.citedreferenceFrancès C, Niang S, Laffitte E, Pelletier F, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005; 52; 1785 – 1793.
dc.identifier.citedreferenceMiyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006; 4; 295 – 306.
dc.identifier.citedreferenceKhamashta M, Taraborelli M, Sciascia S, Tincani A. Antiphospholipid syndrome. Best Pract. Res. Clin. Rheumatol. 2016; 30; 133 – 148.
dc.identifier.citedreferenceLlamas‐Velasco M, Alegría V, Santos‐Briz Á, Cerroni L, Kutzner H, Requena L. Occlusive nonvasculitic vasculopathy. Am. J. Dermatopathol. 2017; 39; 637 – 662.
dc.identifier.citedreferenceCarlson JA, Chen KR. Cutaneous pseudovasculitis. Am. J. Dermatopathol. 2007; 29; 44 – 55.
dc.identifier.citedreferenceMagro CM, Roberts‐Barnes J, Crowson AN. Direct immunofluorescence testing in the diagnosis of immunobullous disease, collagen vascular disease, and vascular injury syndromes. Dermatol. Clin. 2012; 30; 763 – 798, viii.
dc.identifier.citedreferenceHsiao PF, Wu YH. Distinct pattern of direct immunofluorescence in livedoid vasculopathy. Am. J. Dermatopathol. 2010; 32; 240 – 243.
dc.identifier.citedreferenceContestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am. J. Clin. Dermatol. 2014; 15; 517 – 524.
dc.identifier.citedreferenceTorres Saavedra FA, Campo LR, Mendez MV et al. Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: a diagnostic challenge in daily practice. Lupus 2020; 29; 1937 – 1942.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his14440_am.pdf
Size:
1.409MB
Format:
PDF
View/Open
Name:
his14440.pdf
Size:
7.342MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.